Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Large B-Cell, Diffuse × Vinblastine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 17 Lymphoma 10 Urinary Bladder Neoplasms 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Melanoma 3 Urethral Neoplasms 2 Testicular Neoplasms 2 Lymphoma, Large-Cell, Anaplastic 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma 1 Skin Neoplasms 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Rituximab 54 Cyclophosphamide 39 Doxorubicin 34 Vincristine 33 Prednisone 30 Etoposide 16 Radiotherapy 12 Gemcitabine 12 Lenalidomide 11 Filgrastim 10 Peripheral Blood Stem Cell Transplantation 9 Oxaliplatin 9 Cytarabine 9 VAP-cyclo protocol 8 Carmustine 8 Prednisolone 7 Melphalan 7 Mitoxantrone 5 Methotrexate 5 Ifosfamide 5 Bleomycin 5 polatuzumab vedotin 4 Injections 4 pegfilgrastim 3 Vindesine 3 R-CHOP protocol 3 Granulocyte Colony-Stimulating Factor 3 Cyclosporine 3 Carboplatin 3 Busulfan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01148446 2010-06-22

ANZINTER3

Fondazione Italiana Linfomi - ETS

Phase 3 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡